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Abstract
Background: We aimed to evaluate the association between hearing impairment and the prevalence of chronic
kidney disease (CKD) in the largest population-based cross-sectional study to date.
Methods: This cross-sectional study was based on the Korean National Health and Nutritional Examination Survey
(KNHANES). It included 5226 participants ≥19 years of age whose estimated glomerular filtration rate (eGFR) and
hearing threshold had been measured. We diagnosed CKD as an eGFR <60 mL/min/1.73 m2. The participants were
also evaluated for the presence of other contributing factors related to kidney dysfunction. We divided the
participants at the 40-dB threshold into hearing-impairment and no-hearing-impairment groups, using the average
threshold of all six frequencies (500, 1000, 2000, 3000, 4000, and 6000 Hz) for both ears.
Results: The odds of hearing impairment was 1.25 times higher (95 % confidence interval: 1.12–1.64, p-value
< 0.001) in participants with an eGFR <60 mL/min/1.73 m2 than in those with an eGFR ≥60 mL/min/1.73 m2 after
adjustments for age, sex, smoking, alcohol, body mass index, diabetes mellitus, hypertension, dyslipidemia, and
microalbuminuria. Among the risk parameters of CKD associated with hearing impairment, linear regression analysis
adjusted for age and sex determined that each increase of serum creatinine or blood pressure was positively
associated with an increase in hearing threshold (p-value < 0.01).
Conclusion: The odds of hearing impairment were greater with lower eGFR than with normal eGFR. Individuals
with CKD were more likely to also have hearing impairment. We recommend screening the hearing of patients
with CKD to provide earlier identification of hearing impairment and earlier intervention, thereby preventing
progression of hearing impairment and providing appropriate treatment strategies.
Background
The association between chronic kidney disease (CKD)
and hearing impairment was first reported more than
80 years ago by Alport [1], who described a case of
familial kidney disease related to hearing impairment.
With CKD considered to be a major public health con-
cern due to the increase in prevalence in adults, some
studies have subsequently suggested the possibility of a
link between the ear and the kidney [2–4]. However, all of
the current evidence is derived from small observational
studies of patients with CKD or samples of patients with
renal failure. To date, only a small number of large
population-based studies have assessed the association be-
tween nonsyndromal CKD and hearing impairment.
Vilayur et al. [5] reported that moderate CKD was associ-
ated independently with hearing impairment in a large
community-based study after adjusting for age, sex, and
other contributing factors.
The kidney and stria vascularis of the cochlea share
physiologic, ultrastructural, and antigenic similarities
that could explain the link between CKD and hearing
impairment [6]. The similarity between the stria vascu-
laris and the renal tubules could account for why most
nephrotoxic medication is ototoxic in nature [2]. Never-
theless, these reported connections and analogies between
* Correspondence: okas2000@hanmail.net
1Department of Otorhinolaryngology, Yonsei University Wonju College of
Medicine, Wonju, Korea
Full list of author information is available at the end of the article
© 2015 Seo et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Seo et al. BMC Nephrology  (2015) 16:154 
DOI 10.1186/s12882-015-0151-0
the ear and the kidney did not deserve to be formed into
an established hypothesis due to insufficient evidence.
Given that the complication of hearing impairment in pa-
tients with CKD is multifactorial, it should be considered
in hearing impairment studies of patients with CKD that
many multiple contributing factors have been hypothe-
sized to cause hearing impairment, including use of oto-
toxic medications, hypertension, and diabetes, as well as
electrolyte disturbances and hemodialysis itself [7–9].
We conducted a large cross-sectional analysis on the
associations between hearing impairment with CKD in a
representative sample of the adult Korean population
from the Korean National Health and Nutritional Exam-
ination Survey (KNHANES). The aim of this study was
to confirm whether CKD could be an independent con-
tributing factor for hearing impairment and then to
identify which CKD-related risk parameters were im-
portant contributing factors for hearing impairment
among people with nonsyndromal CKD.
Methods
Study population
The KNHANES is a cross-sectional and nationally rep-
resentative survey composed of a health questionnaire
survey, health examination, and nutrition survey. The
KNHANES V was conducted from 2010 to 2012 using a
stratified, multistage probability sampling design, and we
used recent data from the third year (2012) of the
KNHANES V in this study. In the 2012 survey, 10,069 in-
dividuals participated in health interviews, health examin-
ation surveys, and nutritional surveys. A trained otologist
performed face-to-face interviews with each patient to col-
lect a comprehensive medical history that included infor-
mation about the presence of syndromes related to kidney
disease and hearing. We analyzed the data of participants
aged ≥19 years. Participants with any of the following con-
ditions were excluded: (1) history of treatments for renal
failure or syndromes associated with kidney dysfunction
(Alport syndrome, nephrotic syndrome, etc.); (2) history
of chronic otitis media; (3) external- or middle-ear prob-
lems on physical examination; (4) history of noise-induced
hearing impairment; or (5) incomplete hearing results.
Using the questionnaire for quantitative evaluation (his-
tory of occupational noise exposure, duration of noise ex-
posure, use of hearing protective devices, and exposure to
instantaneous environmental noise), 101 patients with
noise-induced hearing impairment were excluded, as
noise-induced damage of the cochlea could create bias
when evaluating the independent role of CKD for hearing.
Exposure to occupational noise was determined according
to whether the participant had worked in a location with
loud machines for ≥3 months. A loud noise was defined
as whether the participant had to raise his or her voice to
hold a conversation.
A total of 5226 participants who underwent audiomet-
ric testing were included in this cross-sectional analysis.
The Korea Centers for Disease Control and Prevention
approved the study protocol, and written informed con-
sent was obtained from all participants before the study
began.
Physical examination and pure-tone audiometry
Ear examinations were performed by ear, nose, and
throat residents using a 4-mm 08 endoscope (Xion
GmbH) and the ML 150 vision system (JRMed Trade).
The air-conduction hearing threshold was measured by
well-trained examiners in a double-walled soundproof
booth using an automatic audiometer (SA-203; Entomed)
at 500, 1000, 2000, 3000, 4000, and 6000 Hz. In this study,
the pure-tone audiogram average was calculated as the
average threshold of all six frequencies. We included the
6000-Hz threshold to detect early presbycusis [10]. We
also calculated average thresholds at low-frequency (500
and 1000 Hz), mid-frequency (2000 and 3000 Hz), and
high-frequency (4000 and 6000 Hz) ranges. After finding
that the average hearing threshold of the left ear (18.0 ±
17.1 dB) appeared to be similar to that of the right ear
(17.6 ± 16.9 dB), we used the average result of both ear
data with CKD for a stricter analysis. Participants were
classified as having a hearing impairment if the average
hearing threshold exceeded 40 dB in each ear [11].
Data collection of possible contributing factors for
hearing impairment
Information on age, sex, residence area (urban or rural),
educational status, smoking exposure, alcohol drinking,
occupation, and other variables in the KNHANES were
obtained through a self-reported survey. Body mass
index (BMI; kg/m2) was calculated by dividing weight by
the height squared. Smoking history was positive if sub-
jects had smoked >5 pack-years during their entire lives.
Alcohol drinking was indicated by the consumption of
at least 30 g/day over the last year. Seoul (the capital city
of South Korea) and six other metropolitan cities were
grouped as urban areas, while the remaining regions
were grouped as rural areas. Educational status was di-
vided into having or not having attended college. Histor-
ies of explosive or occupational noise exposure were
considered positive or negative according to the subjects’
recall. An explosive noise was defined as a sudden loud
noise such as an explosion or gunshot. Exposure to oc-
cupational noise was determined according to whether
the participant had worked in a location with loud ma-
chines for ≥3 months. A loud noise was defined as the
participant having to raise his or her voice to hold a con-
versation. Subjects were asked if they had ever been diag-
nosed with diabetes, hypertension, dyslipidemia, thyroid
dysfunction, or chronic renal failure by a doctor.
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Blood samples were taken after an 8-hour fast during
the period in which this survey was performed. The gly-
cosylated hemoglobin (HbA1C), total cholesterol, trigly-
ceride, high-density lipoprotein cholesterol, low-density
lipoprotein cholesterol, blood urea nitrogen (BUN), and
creatinine concentrations were measured using a Hitachi
7600–110 chemistry analyzer (Hitachi, Tokyo, Japan).
Fasting blood sugar was measured using an auto-
mated analyzer with an enzymatic assay (Pureauto S
GLU; Daiichi, Tokyo, Japan). Urinary albumin was
measured using a turbidimetric immunoassay (Auto-
matic Analyser 7600; Hitachi). To compare the
amount of albumin in each sample against the con-
centration of creatinine in the spot urine sample, the
albumin/creatinine ratio (ACR) was used; microalbu-
minuria was defined as ACR ≥3.5 mg/mmol (female)
or ACR ≥2.5 mg/mmol (male). The estimated glom-
erular filtration rate (eGFR) was determined using the
CKD-EPI formula: eGFR (mL/min/1.73 m2) = 141 ×
min(Scr/κ,1)α ×max(Scr/κ,1) −1.209 × 0.993Age × 1.018, if
female (Scr = serum creatinine, max = the maximum of
Scr/κ or 1, κ = 0.7,α = −0.329 if female) [12]. We focused
on stage III CKD, which was defined for the purposes of
this study as eGFR <60 mL/min/1.73 m2.
Statistical analysis
We used the stratification variables and sampling weights
designated by the Korean Centers for Disease Control and
Prevention. Continuous data are expressed as means and
standard deviation, while categorical data are expressed as
percentages. An independent t-test was used to compare
continuous variables and the chi-square test was used to
compare categorical variables.
Demographic characteristics were analyzed according
to the hearing threshold (<40 or ≥40). Logistic regres-
sion analysis was applied to examine whether hearing
impairment was associated with CKD and was fitted
with increasing degrees of adjustment: a model adjusted
for age (Model 1) and a model adjusted for age, sex,
smoking, alcohol, BMI, DM, HTN, dyslipidemia, and
microalbuminuria (Model 2). Linear regression was used
to assess the associations between risk parameters re-
lated with kidney dysfunction and hearing impairment
with adjustment for age and sex. For the multicollinear-
ity diagnosis among variables, variance inflation factors
(VIF) were calculated for each variable. The VIF pro-
vided an index that could measure how much the vari-
ance of an estimated regression coefficient increased due
to collinearity. The odds ratios (OR) and 95 % confi-
dence intervals (95 % CI) of the associated factors for re-
duced eGFR were determined. Values of P < 0.05 were
considered statistically significant. Statistical analyses
were performed using SPSS version 18.0 (SPSS, Inc.).
Results
The participants’ general and anthropometric charac-
teristics and clinical and laboratory parameters strati-
fied by hearing impairment status are shown in
Table 1. The mean ages of the study participants were
49.6 ± 15.7 years (no-hearing-impairment group) ver-
sus 70.2 ± 9.9 years (hearing-impairment group). The
hearing-impairment group had a worse mean hearing
thresholds (i.e. the mean threshold of both ears) than
the no-hearing-impairment group (54.6 ± 14.3 vs. 13.8
± 9.7 dB, respectively), and there were significant dif-
ferences in hearing thresholds at every frequency
(Fig. 1). Without adjusting for other factors, partici-
pants with a hearing impairment seemed to be more
frequently influenced by hypertension, diabetes, or
dyslipidemia (p-value < 0.05 for all) than those with-
out. The risk parameters (urine albumin, urine cre-
atinine, serum creatinine, BUN, SBP, and DBP) for
kidney dysfunction were worse in the hearing-impairment
group than in the no-hearing-impairment group. Regard-
ing eGFR, the key parameter for CKD, 10.1 % of patients
with no hearing impairment and 47.1 % of patients with
hearing impairments had reduced eGFR (<60 mL/
min/1.73 m2). The ratios of microalbuminuria be-
tween the groups were significantly different; however,
the occurrences in both groups were not high (1.3 %
vs. 2.9 %).
To evaluate which frequencies would be influenced by
low eGFR, we divided the frequencies into three groups
(low-, mid-, and high-frequency ranges). All of the three
groups had meaningful negative correlations with eGFR
values (Fig. 2). Furthermore, through each of the low-,
mid-, and high-frequency ranges, the participants with
low eGFR (<60) had worse hearing thresholds than those
with relatively higher eGFR (≥60; Table 2). The differ-
ence in mean thresholds for the total frequency range
between the groups was significant, similar to those for
the three frequency ranges.
The prevalence of CKD (eGFR <60 mL/min/1.73 m2)
in each group also was analyzed using logistic regression
analysis with adjustment models (Table 3). For hear-
ing impairment, the OR comparing an eGFR <60
versus ≥60 mL/min/1.73 m2 in Model 1 adjusted for
age was 1.41 (95 % CI, 1.08–1.83, p-value- < 0.001). In
Model 2, after adjustment for age, sex, smoking, alco-
hol, BMI, and parameters of chronic disease, the OR
was also significant only for the parameter of eGFR
(OR, 1.25; 95 % CI, 1.12–1.64; p-value < 0.001).
Among the risk parameters of CKD associated with
hearing impairment, linear regression analysis adjusted
for age and sex determined that each increase of serum
creatinine or blood pressure was positively associated
with an increasing hearing threshold (p-value < 0.01;
Table 4). The VIFs of all variables were <2.5, which
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means that those risk parameters had no significant
inter-correlations in this model.
Discussion
In this study, we used KNHANES data to investigate the
potential association between CKD and hearing impair-
ment in Korean adults. An eGFR <60 mL/min/1.73 m2
had a significant independent influence on the hearing
thresholds of adults with nonsyndromal CKD. The OR
of the hearing impairment (as defined by an average
threshold ≥40 dB) was 1.25 times higher in participants
with an eGFR <60 mL/min/1.73 m2 than in those with
an eGFR ≥60 mL/min/1.73 m2 after adjustment for age,
sex, smoking, alcohol, BMI, DM, HTN, Dyslipidemia,
and microalbuminuria. We observed in this study that
CKD (defined as an eGFR <60 mL/min/1.73 m2) could
Table 1 Demographic and clinical characteristics of participants stratified by hearing impairment
Characteristics No hearing impairment (n = 4673) Hearing impairment (n = 515) p-value
Age (years), ≥65 49.6 ± 15.7 70.2 ± 9.9 <0.001
Sex (male)a 1914 (41.0) 253 (49.1) <0.001
BMI (kg/m2) 23.8 ± 3.4 23.6 ± 3.2 0.239
Smoking (current)a 1845 (38.5) 253 (47.5) <0.001
Alcohol (≥30 g/day)a 481 (10.3) 52 (10.1) 0.491
Residence (rural)a 2397 (51.3) 241 (46.7) 0.442
Education (>college)a 1505 (32.2) 52 (10.1) <0.001
Occupationa 0.411
Services and others 518 (11.1) 31 (6.0)
Industry 411 (8.8) 28 (5.5)
Agriculture and fishery 313 (6.7) 63 (12.4)
Hypertension (yes)a 682 (14.6) 156 (30.2) <0.001
Diabetes (yes)a 439 (9.4) 108 (21.0) <0.001
Dyslipidemia (yes)a 715 (15.3) 190 (19.2) 0.046
Thyroid dysfunction (yes)a 78 (1.6) 17 (3.4) 0.081
HbA1C 5.8 ± 0.8 6.01 ± 0.9 <0.001
Blood lipid profile
Total cholesterol 190.3 ± 36.0 189.0 ± 37.5 0.465
HDL cholesterol 52.0 ± 12.6 48.6 ± 11.9 <0.001
LDL cholesterol 121.1 ± 34.9 112.8 ± 38.0 0.076
Triglyceride 130.2 ± 98.4 141.3 ± 123.6 0.062
Urine albumin (ug/ml) 230.2 ± 116.1 392.1 ± 119.8 <0.001
Urine creatinine (mg/dL) 153.5 ± 86.8 122.1 ± 66.3 <0.001
ACR 2.0 ± 1.4 4.1 ± 1.5 <0.001
Microalbuminuriaa 61 (1.3) 15 (2.9) 0.008
Serum creatinine 0.83 ± 0.23 0.89 ± 0.27 <0.001
BUN 14.3 ± 4.3 16.7 ± 5.2 <0.001
eGFR (mL/min/1.73 m2) 91.9 ± 26.4 63.6 ± 19.7 <0.001
eGFR < 60a 472 (10.1) 243 (47.1) <0.001
SBP (mmHg) 118.8 ± 16.6 128.6 ± 17.4 <0.001
DBP (mmHg) 75.9 ± 10.4 74.2 ± 10.2 <0.001
Mean hearing level (dB) 13.8 ± 9.7 54.6 ± 14.3 <0.001
Data expressed as mean ± SD, p < 0.05 was set as the significance level, and significant differences between groups are shown in bold. We divided the participants
at the 40-dB threshold into the hearing-impairment and no-hearing-impairment groups, using the average threshold of all six frequencies (500, 1000, 2000, 3000,
4000, and 6000 Hz) for both ears
BMI body mass index, HbA1C glycosylated hemoglobin, HDL high-density lipoprotein, LDL low-density lipoprotein, UACR urinary albumin creatinine ratio, BUN
blood urea nitrogen, eGFR estimated glomerular filtration rate, BUN blood urea nitrogen, SBP systolic blood pressur, DBP diastolic blood pressure, dB decibel, micro-
albuminuria defined as ACR ≥3.5 mg/mmol (female) or ACR ≥2.5 mg/mmol (male)
aData are expressed as number (%) unless otherwise indicated
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affect hearing impairment independently. Blood pressure
and serum creatinine were found to be positively corre-
lated with hearing impairment among kidney dysfunc-
tion–related risk parameters.
Recent research in a large Australian population re-
ported a relatively high prevalence of hearing impair-
ment associated with moderate CKD, and more than
half of the participants with CKD had any level of hear-
ing impairment [5]. Others demonstrated that the high
frequency thresholds were significantly higher for patients
with CKD [2–4]. Morton et al. [3] showed an increasing
incidence of hearing impairment in hemodialysis patients
that was unrelated to ototoxic drugs. Antonelli et al. [13]
reported that 39.1 % of patients with CKD had an abnor-
mal auditory brainstem response compared with 23.9 % of
controls. Furthermore, in another prospective study evalu-
ating cochlear functioning in patients (18–45 years old)
with varying stages of CKD, 46 % of the participants with
later-stage CKD presented with early cochlear dysfunction
and subclinical hearing impairment [14]. Our findings are
in line with these studies. However, there were significant
differences through all of the frequencies on both ears in
our study, not only for the high frequency range. This is
why we compared the mean thresholds for the total fre-
quency range with eGFR. According to Gelfand’s hearing
impairment criteria [11], people who presented with
Fig. 1 Mean hearing thresholds on both ears in both groups. The hearing thresholds were worse significantly at every frequency in the hearing-
impairment group than in the no-hearing-impairment group
Fig. 2 The correlation between eGFR and mean thresholds at low- (a), mid-(b), and high-(c) frequency ranges. All of the three groups had
meaningful negative correlations with eGFR values (all p < 0.001)
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hearing thresholds of ≤25 dB were considered to have nor-
mal hearing as indicated by normative data. However, as
socially serviceable hearing is within 40 dB and disabling
hearing impairment refers to hearing impairment >40 dB
[15], we divided the participants at the 40-dB threshold
into the hearing-loss and no-hearing-loss groups. This
eliminated participants with a hearing threshold of 25–
40 dB, making the difference in eGFR clearer at every fre-
quency discriminated.
The pathophysiology between hearing impairment and
CKD remains unclear. Various factors can contribute to
cochlear dysfunction in patients with CKD, and a com-
bination and interaction of several factors could result in
reduced cochlear functioning in patients with CKD. The
cochlea and the kidney show noteworthy similarities
such as membranous structures, the central role of cili-
ated epithelial cells, and tubular organization [6]. One
research group hypothesized that some inner ear disor-
ders may depend on a large decrease in blood pressure
values associated with abnormal peripheral vasoconstric-
tion [16]. Others reported that cochlear dysfunction
could be attributed to a combination of factors including
abnormal electrolytes, urea, and creatinine levels, as well
as concomitant conditions such as hypertension and
ototoxic medication. Antonelli et al. [10] did not find a
significant correlation between BUN or serum creatinine
level and hearing impairment. In experimental uremic
animals, a significant decrease in Na+-K+-ATPase activ-
ity resulted in hearing impairment [17]. We tested for
such correlations between hearing impairment and risk
parameters with kidney dysfunction. Both serum creatin-
ine and high blood pressure could be important inde-
pendent contributing factors of disturbed cochlear
function. In the presence of a low eGFR (<60 mL/min/
1.73 m2), blood pressure treatment should be considered
to preserve hearing function. Such a finding in this
large-population study, performed by adjusting related
important contributing factors, may be meaningful,
compared with other small studies.
Ototoxic medication, including furosemide, can affect
ionic gradients between the endolymph and perilymph,
resulting in edema of the epithelium of the stria vascu-
laris [18]. It is further indicated in the literature that fur-
osemide affects cochlear function by altering the
endocochlear potential [19]. In our study, we excluded
53 syndromes associated with the kidney (Alport syn-
drome, nephrotic syndrome, etc.) by using the question-
naire. We also excluded participants with a history of




Unadjusted Adjusted with Age
eGFR≥60 eGFR <60 β (SE) p-value β (SE) p-value
(n = 4245) (n = 716)
Low-frequency 13.5 ± 12.3 29.2 ± 18.7 −0.101(0.006) <0.001 −0.032(0.008) 0.047
Mid-frequency 16.4 ± 16.1 38.1 ± 20.8 −0.103(0.007) <0.001 −0.078(0.009) 0.033
High frequency 27.8 ± 21.3 53.9 ± 22.6 −0.107(0.009) <0.001 −0.047(0.011) 0.042
Total frequency 14.9 ± 13.4 33.6 ± 18.9 −0.152(0.006) <0.001 −0.050(0.008) 0.021
Data expressed as mean ± SD, p < 0.05 was set as the significance level, and significant differences between groups are shown in bold
eGFR estimated glomerular filtration rate, low-frequency (500 and 1000 Hz), mid-frequency (2000 and 3000 Hz), and high-frequency (4000 and 6000 Hz) ranges. β
unstandardized coefficient, SE standard error
Table 3 Multiple logistic regression analysis between parameter
of chronic disease and hearing impairment
Odds ratio (95 % confidence interval)
Parameter Model 1 p-value Model 2 p-value
eGFR <60 1.41 (1.08, 1.83) <0.001 1.25 (1.12, 1.64)a <0.001
HTN 0.87 (0.44, 1.72) 0.097 0.97 (0.46, 2.04)b 0.967
DM 1.07 (0.49, 2.33) 0.089 0.77 (0.99, 5.88)c 0.161
Dyslipidemia 1.35 (0.14, 12.92) 0.794 0.92 (0.71, 1.19)d 0.505
Microalbuminuria 1.00 (0.99, 1.01) 0.187 1.15 (0.57, 2.33)e 0.699
Model 1 adjusted for age
Model 2 aadjusted for age, sex, smoking, alcohol, BMI, DM, HTN, dyslipidemia,
and microalbuminuria; badjusted for age, sex, BMI, DM, eGFR <60, dyslipidemia,
and microalbuminuria; cadjusted for age, sex, BMI, HTN, eGFR <60, dyslipidemia,
and microalbuminuria; dadjusted for age, sex, BMI, DM, HTN, eGFR <60, and
microalbuminuria; eadjusted for age, sex, BMI, DM, HTN, eGFR <60,
and dyslipidemia
BMI body mass index, eGFR estimated glomerular filtration rate, DM diabetes
mellitus, HTN hypertension; microalbuminuria, albumin/creatinine ratio
(ACR) ≥3.5 mg/mmol (female) or ACR ≥2.5 mg/mmol (male), CI confidence
interval, OR odds ratio
Table 4 Multiple linear regression analysis for the mean hearing
thresholds (dB) by risk parameters related to kidney dysfunction
β (SE) P value
Serum creatinine 2.29 (1.01) <0.01
BUN 0.56 (0.05) 0.08
Microalbuminuria −0.02 (0.01) 0.76
Urinary creatinine −0.23 (0.01) 0.27
HbA1C 2.08 (0.26) 0.49
SBP 0.31 (0.02) <0.01
DBP 0.33 (0.03) <0.01
Values were adjusted for age and sex
BUN blood urea nitrogen, HbA1C glycosylated hemoglobin, SBP systolic blood
pressure, DBP diastolic blood pressure, β unstandardized coefficient, SE
standard error
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chronic renal failure. However, we could not obtain the
history of use of ototoxic medication, such as NSAIDs
or furosemide, as such data was not collected in this
survey.
Taken together, these observations support the hy-
pothesis of a close correlation between kidney dysfunc-
tion and cochlea impairment. The cochlea appears to be
most influenced independently by CKD, which can
translate into hearing impairment in adults. Although
prospective studies are required to assess this association
between CKD and hearing impairment, our results have
considerable validity in that we confirmed this correl-
ation in the largest population of participants to date
after adjustment for other contributing factors and ana-
lyzed the study using the questionnaire and a laboratory
assessment. We recommend that screening the hearing
of patients with CKD to provide earlier identification of
hearing impairment and earlier intervention, thereby
preventing progression of hearing impairment and pro-
viding appropriate treatment strategies.
Conclusion
The odds of hearing impairment were greater with lower
eGFR than with normal eGFR. Our conclusion is that
CKD combined with hypertension may be an important
factor in disturbing hearing thresholds. Further studies
may well reveal the common pathophysiology between
kidney dysfunction and cochlear impairment.
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